Literature DB >> 24929057

Measurement of plasma protein and lipoprotein binding of pyrethroids.

Pankaj K Sethi1, S Muralidhara2, James V Bruckner3, Catherine A White4.   

Abstract

INTRODUCTION: A simple, reliable procedure was developed to measure binding of pyrethroid insecticides to total proteins and lipoproteins of rat and human plasma.
METHODS: The extent of binding of (14)C-labeled deltamethrin (DLM), cis-permethrin (CIS) and trans-permethrin (TRANS) was quantified by a 3-step organic solvent extraction technique. Rat and human plasma samples, containing NaF to inhibit esterases, were spiked with a range of concentrations of each radiolabeled pyrethroid. Protein binding reached equilibrium within ~1h of incubation at 37°C. The samples were extracted in turn with: isooctane to collect the unbound fraction; 2-octanol to extract the lipoprotein-bound fraction; and acetonitrile to obtain the protein-bound fraction.
RESULTS: Absolute recoveries of DLM, CIS and TRANS ranged from 86 to 95%. Adherence of these very lipophilic chemicals to glass and plastic was minimized by using silanized glass vials and LoBind® plastic pipettes. The method's ability to distinguish lipoprotein from protein binding was confirmed by experiments with diazepam and cyclosporine, drugs that bind selectively to albumin and lipoproteins, respectively. DISCUSSION: This procedure was effectively utilized for studies of the species-dependence of plasma protein and lipoprotein binding of three pyrethroids for inclusion in physiologically-based pharmacokinetic models of pyrethroids for use in health risk assessments of the insecticides in children and adults.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Binding; Cyclosporine binding; Deltamethrin; Diazepam binding; Lipoproteins; Method; Permethrin; Plasma proteins; Pyrethroid; Solvent extraction

Mesh:

Substances:

Year:  2014        PMID: 24929057     DOI: 10.1016/j.vascn.2014.06.002

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  4 in total

1.  The serum metabolomics signature of type 2 diabetes is obscured in Alzheimer's disease.

Authors:  Jill K Morris; Brian D Piccolo; Kartik Shankar; John P Thyfault; Sean H Adams
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-12-26       Impact factor: 4.310

2.  Ontogeny of plasma proteins, albumin and binding of diazepam, cyclosporine, and deltamethrin.

Authors:  Pankaj K Sethi; Catherine A White; Brian S Cummings; Ronald N Hines; Srinivasa Muralidhara; James V Bruckner
Journal:  Pediatr Res       Date:  2015-11-16       Impact factor: 3.756

3.  Application of a UPLC-MS/MS method to the protein binding study of TM-2 in rat, human and beagle dog plasma.

Authors:  Hui Liu; Pan-Pan Wu; Ming-Jing Yang; Lei Men; Hong-Li Lin; Yun-Li Zhao; Xing Tang; Zhi-Guo Yu
Journal:  J Pharm Anal       Date:  2015-08-12

4.  Physiologically Based Pharmacokinetic Modeling in Risk Assessment: Case Study With Pyrethroids.

Authors:  Pankajini Mallick; Gina Song; Alina Y Efremenko; Salil N Pendse; Moire R Creek; Thomas G Osimitz; Ronald N Hines; Paul Hinderliter; Harvey J Clewell; Brian G Lake; Miyoung Yoon; Marjory Moreau
Journal:  Toxicol Sci       Date:  2020-08-01       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.